Comparison of Intense Pulsed Light Treatments Including Upper Lid or Lateral Canthus in Patients of Meibomian Gland Dysfunction

Overview

Journal J Clin Med

Specialty General Medicine

Date 2024 Jun 27

PMID 38930110

Authors

Ji Sang Min

Ikhyun Jun

Tae-Im Kim

Reiko Arita

Kyoung Yul Seo

Affiliations

Soon will be listed here.

Abstract

To determine the differences in the effects of intense pulsed light (IPL) treatment when including the upper and lower lid or lateral canthus area in patients with meibomian gland dysfunction (MGD). Patients who underwent three IPL treatment sessions at 3-week intervals were divided into three groups according to the treatment sites: group A, lower lid; group B, upper and lower lids; and group C, lower lid and lateral canthal area. Before and after the IPL treatment sessions, we obtained the lid abnormality score (LAS), meibum expressibility (ME), meibum quality (MQ), lipid layer thickness (LLT), type I Schirmer test (ST), tear break-up time (TBUT) test, corneal fluorescein staining scores (CFSs), and Ocular Surface Disease Index (OSDI). IPL treatment significantly improved LASs, ME, MQ, TBUT, CFS, and OSDI values in all groups. Differences in LAS values before and after IPL treatment were significantly greater in groups B and C than those in group A. IPL treatment encompassing the upper lid and lateral canthus together with the lower lid elicited additional improvement in patients with MGD. The additional effect on treating the lateral canthus was similar to the effect observed on the additional treatment of the upper lid.

References

Tashbayev B, Yazdani M, Arita R, Fineide F, Utheim T . Intense pulsed light treatment in meibomian gland dysfunction: A concise review. Ocul Surf. 2020; 18(4):583-594. DOI: 10.1016/j.jtos.2020.06.002. View

Geerling G, Tauber J, Baudouin C, Goto E, Matsumoto Y, OBrien T . The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction. Invest Ophthalmol Vis Sci. 2011; 52(4):2050-64. PMC: 3072163. DOI: 10.1167/iovs.10-6997g. View

Tang Y, Liu R, Tu P, Song W, Qiao J, Yan X . A Retrospective Study of Treatment Outcomes and Prognostic Factors of Intense Pulsed Light Therapy Combined With Meibomian Gland Expression in Patients With Meibomian Gland Dysfunction. Eye Contact Lens. 2020; 47(1):38-44. PMC: 7752209. DOI: 10.1097/ICL.0000000000000704. View

Giannaccare G, Taroni L, Senni C, Scorcia V . Intense Pulsed Light Therapy In The Treatment Of Meibomian Gland Dysfunction: Current Perspectives. Clin Optom (Auckl). 2019; 11:113-126. PMC: 6802620. DOI: 10.2147/OPTO.S217639. View

Chen Y, Li J, Wu Y, Lin X, Deng X, Yun-E Z . Comparative Evaluation in Intense Pulsed Light Therapy Combined with or without Meibomian Gland Expression for the Treatment of Meibomian Gland Dysfunction. Curr Eye Res. 2020; 46(8):1125-1131. DOI: 10.1080/02713683.2020.1867750. View

Yun J, Min J . Skin temperature change in patients with meibomian gland dysfunction following intense pulsed light treatment. Front Med (Lausanne). 2022; 9:893940. PMC: 9399455. DOI: 10.3389/fmed.2022.893940. View

Min J, Yoon S, Kim K, Jun I, Kim E, Kim T . Treatment Effect and Pain During Treatment With Intense Pulsed-Light Therapy According to the Light Guide in Patients With Meibomian Gland Dysfunction. Cornea. 2021; 41(2):177-182. DOI: 10.1097/ICO.0000000000002859. View

Vora G, Gupta P . Intense pulsed light therapy for the treatment of evaporative dry eye disease. Curr Opin Ophthalmol. 2015; 26(4):314-8. DOI: 10.1097/ICU.0000000000000166. View

Raulin C, Greve B, Grema H . IPL technology: a review. Lasers Surg Med. 2003; 32(2):78-87. DOI: 10.1002/lsm.10145. View

10.

Arita R, Itoh K, Maeda S, Maeda K, Furuta A, Fukuoka S . Proposed diagnostic criteria for obstructive meibomian gland dysfunction. Ophthalmology. 2009; 116(11):2058-63.e1. DOI: 10.1016/j.ophtha.2009.04.037. View

11.

Gupta P, Vora G, Matossian C, Kim M, Stinnett S . Outcomes of intense pulsed light therapy for treatment of evaporative dry eye disease. Can J Ophthalmol. 2016; 51(4):249-253. DOI: 10.1016/j.jcjo.2016.01.005. View

12.

Craig J, Chen Y, Turnbull P . Prospective trial of intense pulsed light for the treatment of meibomian gland dysfunction. Invest Ophthalmol Vis Sci. 2015; 56(3):1965-70. DOI: 10.1167/iovs.14-15764. View

13.

Toyos R, McGill W, Briscoe D . Intense pulsed light treatment for dry eye disease due to meibomian gland dysfunction; a 3-year retrospective study. Photomed Laser Surg. 2015; 33(1):41-6. PMC: 4298157. DOI: 10.1089/pho.2014.3819. View

14.

Fitzpatrick T . The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol. 1988; 124(6):869-71. DOI: 10.1001/archderm.124.6.869. View

15.

Erdogmus S, Govsa F . The arterial anatomy of the eyelid: importance for reconstructive and aesthetic surgery. J Plast Reconstr Aesthet Surg. 2007; 60(3):241-5. DOI: 10.1016/j.bjps.2006.01.056. View

16.

Kim M, Min J . Effect of Intense Pulsed-Light Treatment Using a Novel Dual-Band Filter in Patients with Meibomian Gland Dysfunction. J Clin Med. 2022; 11(13). PMC: 9267678. DOI: 10.3390/jcm11133607. View

17.

Arita R, Minoura I, Morishige N, Shirakawa R, Fukuoka S, Asai K . Development of Definitive and Reliable Grading Scales for Meibomian Gland Dysfunction. Am J Ophthalmol. 2016; 169:125-137. DOI: 10.1016/j.ajo.2016.06.025. View

18.

Nelson J, Shimazaki J, Benitez-Del-Castillo J, Craig J, McCulley J, Den S . The international workshop on meibomian gland dysfunction: report of the definition and classification subcommittee. Invest Ophthalmol Vis Sci. 2011; 52(4):1930-7. PMC: 3072158. DOI: 10.1167/iovs.10-6997b. View

19.

Feng J, Wang J, Wu B, Shao Q, Zang Y, Cao K . Association of meibomian gland morphology with orifice plugging and lid margin thickening in meibomian gland dysfunction patients. Int Ophthalmol. 2023; 43(9):3207-3218. DOI: 10.1007/s10792-023-02721-2. View

20.

Xue A, Wang M, Ormonde S, Craig J . Randomised double-masked placebo-controlled trial of the cumulative treatment efficacy profile of intense pulsed light therapy for meibomian gland dysfunction. Ocul Surf. 2020; 18(2):286-297. DOI: 10.1016/j.jtos.2020.01.003. View